1887

Abstract

In this study the minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) of 5-hydroxytryptamine (5 HT, serotonin) against clinical isolates of ( = 11), ( = 9), ( = 10) and s (ATCC 22019) using a broth microdilution test were investigated. In addition, it was examined whether delayed regrowth as a post-antifungal effect results following short exposure to 5 HT. 5 HT showed antifungal activity towards all isolates of spp. The isolates yielded comparable MIC and MFC values of 5 HT in the range 0.91–7.34 mM and 1.83–14.68 mM, respectively. A lag in regrowth was dependent on the concentration tested. Treatment for 3 h at concentrations of 5 HT below and equipotent to the MFC resulted in a delayed regrowth of 8–12 h for isolates of spp. In conclusion, these studies clearly demonstrate antifungal effects of 5 HT. Identifying the mode of action could be of great help in developing and researching new antifungal drugs.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.04987-0
2003-02-01
2020-01-23
Loading full text...

Full text loading...

/deliver/fulltext/jmm/52/2/169.html?itemId=/content/journal/jmm/10.1099/jmm.0.04987-0&mimeType=html&fmt=ahah

References

  1. Brown, M. W. ( 1975;). In vitro antibacterial activity of drugs against human intestinal anaerobic bacteria. J Pharm Sci 64, 700–702.[CrossRef]
    [Google Scholar]
  2. Cederlund, H. & Mardh, P. A. (1993). Antibacterial activities of non-antibiotic drugs. J Antimicrob Chemother 32, 355–365.
  3. Christin, L., Wysong, T., Meshulam, R., Hastey, E., Simons, E. R. & Diamond, R. ( 1998;). Human platelets damage Aspergillus fumigatus hyphae and may supplement killing neutrophils. Infect Immun 66, 1181–1189.
    [Google Scholar]
  4. Coutaux, A. F., Mooney, J. J. & Wirth, D. F. ( 1994;). Neuronal monoamine reuptake inhibitors enhance in vitro susceptibility to chloroquine in resistant Plasmodium falciparum. Antimicrob Agents Chemother 38, 1419–1421.[CrossRef]
    [Google Scholar]
  5. Dimmock, P. W., Wyatt, K. M., Jones, P. W. & O'Brien, P. M. (2000). Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systemic review. Lancet 356, 1131–1136.
  6. Harenbe, J., Huhle, G., Giese, C., Wang, L., Feuring, M. & Song, X. & Hoffman, U. (2000). Determination of serotonin release from platelets by enzyme immunoassay in the diagnosis of heparin-induced thrombocytopenia. Br J Haematol 109, 182–186.
  7. Helmeste, D., Tang, S. W. & Vu, R. (1998). Inhibition of platelet serotonin uptake by cytochrome P 450 inhibitors miconazole and econazole. Life Sci 62, 2203–2208.
  8. Kumar, A., Kumar, M., Deepika, K., Fernandez, J. & Eisdorfer, C. (1990). A modified HPLC technique for simultaneous measurement of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in cerebrospinal fluid, platelet and plasma. Life Sci 47, 1751–1759.
  9. Larsson, M., Hagberg, L., Norkans, G. & Forsman, A. (1989). Indole amine deficiency in blood and cerebrospinal fluid from patients with human immunodeficiency virus infection. J Neurosci Res 23, 441–446.
  10. Lass-Flörl, C., Dierich, M., Fuchs, D., Semenitz, E. & Ledochowski, M. (2001a). Antifungal activity against Candida species of the selective serotonin reuptake inhibitor sertraline. Clin Infect Dis 33, e135–e136.
  11. Lass-Flörl, C., Dierich, M., Fuchs, D., Semenitz, E., Jenewein, I. & Ledochowski, M. (2001b). Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro. J Antimicrob Chemother 48, 775–779.
  12. Lass-Flörl, C., Wiedauer, B., Mayr, A., Kirchmair, M., Jenewein, I., Ledochowski, M. & Dierich, M. P. (2002). Antifungal properties of 5-HT (serotonin) against Aspergillus spp. in vitro. Int J Med Microbiol 291, 655–657.
  13. Munoz-Bellido, J. L., Munoz-Criado, S. & Garcia-Rodriguez, J. A. (1996). In vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2). J Antimicrob Chemother 37, 1005–1009.
  14. Munoz-Bellido, J. L., Munoz-Criado, S. & Garcia-Rodriguez, J. A. (2000). Antimicrobial activity of psychotropic drugs selective serotonin reuptake inhibitors. Int J Antimicrob Agents 14, 177–180.
  15. Nagl, M., Hengster, P., Semenitz, E. & Waldemar, G. (1999). The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model. J Antimicrob Chemother 43, 804–809.
  16. National Committee for Clinical Laboratory Standards (1997). Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, MA-27. Villa Nova, PA: NCCLS.
  17. Rendu, F., Breton-Gorius, J., Lebret, M., Klebanoff, C., Buriot, D., Griscelli, C., Levy-Toledano, S. & Caen, J. P. (1983). Evidence that abnormal platelet functions in human Chediak–Higashi syndrome are the result of a lack of dense bodies. Am J Pathol 111, 307–314.
  18. Schloss, P. & Williams, D. (1998). The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol 12, 115–121.
  19. Schuff-Werner, P. & Splettstoesser, W. (1999). Antioxidative properties of serotonin and the bactericidal function of polymorphonuclear phagocytes. In Tryptophan, Serotonin, and Melatonin: Basic Aspects and Applications, pp. 321–325. Edited by G. Huether, T. Kochen, T. J. Simat & H. Steinhart. New York: Kluwer/Plenum.
  20. Tu, J. & Zellweger, H. ( 1965;). Blood-serotonin deficiency in Down's syndrome. Lancet ii, 715–716.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.04987-0
Loading
/content/journal/jmm/10.1099/jmm.0.04987-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error